Hikma Pharmaceuticals PLC 2008 AR2
The report outlines Hikma's corporate and social responsibility initiatives and performance for the year 2008. Key highlights include the restructuring of its CSR governance with new Board-level and Working Committees, and the expansion of its CSR Champions program. The company aligned its reporting with the GRI G3 guidelines, focusing on community investments, environmental impacts, and labor practices. Hikma made significant community investments totaling over $2.49 million, including medicine donations and funding for poverty alleviation. Additionally, the company achieved ISO 14001 certification for its main plants in Jordan and implemented various energy and water-saving initiatives.
Company: Hikma Pharmaceuticals PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2008
Type: AR2
Pages: 8
Back to company
Hikma Pharmaceuticals PLC
Annual Report
The report outlines Hikma's corporate and social responsibility initiatives and performance for the year 2008. Key highlights include the restructuring of its CSR governance with new Board-level and Working Committees, and the expansion of its CSR Champions program. The company aligned its reporting with the GRI G3 guidelines, focusing on community investments, environmental impacts, and labor practices. Hikma made significant community investments totaling over $2.49 million, including medicine donations and funding for poverty alleviation. Additionally, the company achieved ISO 14001 certification for its main plants in Jordan and implemented various energy and water-saving initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2008
Reporting Period
2008
Fiscal Year
2008
Published
Mar 31, 2009
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
No data available